Clinical studies with herpes simplex virus type 2 Curtis strain vaccine.
Corey
L
L
Department of Laboratory Medicine, University of Washington, Seattle 98105.
D000914:Antibodies, Viral / Q000096:biosynthesis; D004311:Double-Blind Method; D004341:Drug Evaluation; D005260:Female; D005500:Follow-Up Studies; D006558:Herpes Genitalis / Q000517:prevention & control*; D006801:Humans; D007111:Immunity, Cellular; D008297:Male; D011446:Prospective Studies; D012747:Sexual Partners; D018139:Simplexvirus / Q000276:immunology*; D014611:Vaccination; D014759:Viral Envelope Proteins / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology
D000914:Antibodies, Viral; D014759:Viral Envelope Proteins; D014765:Viral Vaccines; C044525:glycoprotein B, herpes simplex virus type 2; C040570:glycoprotein D-herpes simplex virus type 2